Cargando…

Interferons and their potential in the treatment of ocular inflammation

Since their discovery in the 1950s interferons have been the scope of investigation in many diseases as therapeutic as well as pathogenetic factors. We know they have immune stimulatory and immune regulatory effects. This apparently counter-intuitive mechanism can be summarized as immunomodulatory a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mackensen, Friederike, Max, Regina, Becker, Matthias D
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770867/ https://www.ncbi.nlm.nih.gov/pubmed/19898628

Ejemplares similares

Ocular outcome and frequency of neurological manifestations in patients with acute posterior multifocal placoid pigment epitheliopathy (APMPPE)
por: Thomas, Bettina C., et al.
Publicado: (2012)

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2
por: Becker, J C, et al.
Publicado: (2002)

Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization
por: Mansour, Ahmad M, et al.
Publicado: (2012)

Interferon and Ocular Viral Disease
por: Galin, Miles A., et al.
Publicado: (1970)

Ocular Inflammation Post-Vaccination
por: Zou, Yaru, et al.
Publicado: (2023)

Difluprednate for the prevention of ocular inflammation postsurgery: an update
por: Donnenfeld, Eric D
Publicado: (2011)

Purinergic Receptors in Ocular Inflammation
por: Guzman-Aranguez, Ana, et al.
Publicado: (2014)

From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
por: Dammak, Azza, et al.
Publicado: (2021)

The regulation of inflammation by interferons and their STATs
por: Rauch, Isabella, et al.
Publicado: (2013)

Ocular Inflammation
por: Huerva, Valentín, et al.
Publicado: (2015)

Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence
por: Rajpal, Rajesh K, et al.
Publicado: (2014)

PPAR-γ, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches
por: Malchiodi-Albedi, Fiorella, et al.
Publicado: (2008)

Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia
por: Nuruddin, Murtuza, et al.
Publicado: (2022)

Adjuvant Topical Interferon Alpha 2b for the Treatment of Monkeypox Ocular Manifestations
por: Arteaga-Rivera, José Y., et al.
Publicado: (2023)

Ocular Sporotrichosis
por: Ramírez-Soto, Max Carlos, et al.
Publicado: (2021)

Mode of Managing Ocular Inflammations
por: Whyte, D.
Publicado: (1802)

Immune Fingerprint in Diabetes: Ocular Surface and Retinal Inflammation
por: Amorim, Madania, et al.
Publicado: (2023)

Thermography in ocular inflammation
por: Kawali, Ankush A
Publicado: (2013)

Ocular Inflammation and Infection
por: Callegan, Michelle, et al.
Publicado: (2012)

Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes
por: Feng, Emily, et al.
Publicado: (2021)

Interferon lambda in inflammation and autoimmune rheumatic diseases
por: Goel, Rishi R., et al.
Publicado: (2021)

Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia
por: Ghaffari, Reza, et al.
Publicado: (2021)

A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation
por: Joossen, Cedric, et al.
Publicado: (2020)

Long-term pegylated interferon-α and its potential in the treatment of melanoma
por: Dummer, Reinhard, et al.
Publicado: (2009)

An Eye on Staphylococcus aureus Toxins: Roles in Ocular Damage and Inflammation
por: Astley, Roger, et al.
Publicado: (2019)

Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation
por: Wang, Xudong, et al.
Publicado: (2023)

Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate
por: Comstock, Timothy L., et al.
Publicado: (2012)

Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation
por: Mazet, Roseline, et al.
Publicado: (2020)

Therapeutic potential of interferon-gamma in tuberculosis
por: Berns, Svetlana A., et al.
Publicado: (2022)

Ocular Microbiota and Intraocular Inflammation
por: Li, Jing Jing, et al.
Publicado: (2020)

Role of Innate Interferon Responses at the Ocular Surface in Herpes Simplex Virus-1-Induced Herpetic Stromal Keratitis
por: Ren, Jiayi, et al.
Publicado: (2023)

Ocular Manifestations and Potential Treatments of Alport Syndrome: A Systematic Review
por: Ramakrishnan, Rahul, et al.
Publicado: (2022)

Ranibizumab for the treatment of degenerative ocular conditions
por: Triantafylla, Magdalini, et al.
Publicado: (2014)

Updates in the treatment of ocular allergies
por: Kari, Osmo, et al.
Publicado: (2010)

Interferon Independent Non-Canonical STAT Activation and Virus Induced Inflammation
por: Nan, Yuchen, et al.
Publicado: (2018)

Therapeutic Potential of Honey and Propolis on Ocular Disease
por: Abd Rashid, Norhashima, et al.
Publicado: (2022)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Interferon alpha-2b in giant ocular surface squamous neoplasia
por: Hernandez-Bogantes, Erick, et al.
Publicado: (2016)

Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface Diseases
por: Li, Fei, et al.
Publicado: (2016)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
por: Ll Wilkinson, Meredyth G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tkag7enr3d2f84petbf4hbk7tf